[Urinary porphyrin excretion in human immunodeficiency virus infection]

F Mouly1, M Janier, Y Nordmann

  • 1Policlinique de Dermatologie, Hôpital Saint-Louis, Paris.

Presse Medicale (Paris, France : 1983)
|October 26, 1996
PubMed

Insights

Human immunodeficiency virus (HIV) infection is not directly linked to altered porphyrin metabolism. Liver disorders, common in HIV patients, are more likely causes of these metabolic changes.

Area of Science:

  • Biochemistry
  • Virology
  • Hepatology

Context:

  • Porphyria cutanea tarda (PCT) is a known complication in some human immunodeficiency virus (HIV) patients.
  • Previous reports indicate PCT in approximately 60 HIV-infected individuals since 1987.
  • The role of HIV infection in porphyrin metabolism disorders, beyond overt PCT, remains unclear.

Purpose:

  • To investigate porphyrin metabolism disorders in HIV-infected patients without clinically apparent PCT.
  • To assess urinary porphyrin excretion patterns in a cohort of HIV-positive individuals.

Summary:

  • Urinary porphyrin levels were analyzed in 64 HIV-infected patients.
  • Abnormal porphyrin excretion was detected in 36% of patients, with 6% showing patterns suggestive of PCT.
  • Increased coproporphyrinuria was observed in 23% of patients.
  • Abnormalities were more prevalent in patients with existing liver disease or advanced HIV/AIDS.
  • One patient later developed PCT, two years after the initial assessment.

Impact:

  • HIV infection itself may not directly cause altered porphyrin metabolism.
  • The high frequency of liver disorders in HIV patients likely contributes to observed porphyrin abnormalities.
  • Findings suggest that underlying hepatopathy is a significant factor in porphyrin metabolism disturbances among HIV-infected individuals.
Abstract

Related Concept Videos

Drug Elimination by Renal Route: Tubular Reabsorption01:22

Drug Elimination by Renal Route: Tubular Reabsorption

During the process of renal excretion, as the glomerular filtrate progresses to the distal convoluted tubule (DCT), drugs that are highly permeable, lipophilic, and nonionized undergo passive reabsorption from the tubular fluid into the surrounding peritubular capillaries. This reabsorption process restricts their elimination through the kidneys. However, the majority of drugs are either weak acids or weak bases, and their ionization level is dependent on pH. By altering the pH of urine, the...
Drug Elimination by Renal Route: Tubular Secretion01:15

Drug Elimination by Renal Route: Tubular Secretion

Once the process of glomerular filtration is completed, blood carrying unfiltered drug molecules traverses through efferent arterioles and makes its way into the peritubular capillaries in the proximal tubule. A variety of carriers play a pivotal role in actively secreting drugs from these peritubular capillaries into the tubular fluid. The organic anion transporter transfers acidic drugs, against an electrochemical gradient, from the peritubular capillaries into the renal tubule cells and...
Renal Drug Excretion: Tubular Secretion01:28

Renal Drug Excretion: Tubular Secretion

Active tubular secretion is a robust, energy-demanding process that utilizes carrier systems to transport drugs into renal tubules. The active renal secretion systems include the organic anion transporter (OAT) for weak acids and the organic cation transporter (OCT) for weak bases. Structurally similar drugs can compete for the same transporter, potentially leading to drug accumulation and toxicity. However, this principle can be exploited therapeutically. One example is probenecid (Probalan),...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Urinary Tract Infection II: Pathophysiology01:25

Urinary Tract Infection II: Pathophysiology

The pathophysiology of urinary tract infections (UTIs) encompasses several progressive stages, beginning with bacterial colonization and culminating in potential systemic complications if untreated. UTIs are primarily initiated by bacteria, such as Escherichia coli, which often originate from the gastrointestinal tract and migrate to the urinary system through the periurethral area. This migration can occur via several routes, including improper hygiene practices, sexual activity, or...
Urine Studies I: Urinalysis01:29

Urine Studies I: Urinalysis

Urinalysis is a widely used diagnostic test that analyzes urine's physical, chemical, and microscopic characteristics. Healthcare providers use it to detect and monitor various health conditions, including renal disease, urinary tract infections (UTIs), diabetes, and metabolic or systemic disorders.Components of UrinalysisUrinalysis consists of three primary components: physical, chemical, and microscopic examination. Each provides unique insights into the urine sample and, by extension, the...